As a dietary supplement, Nicadan™ tablets are beneficial in maintaining overall skin health, especially in patients with inflammatory skin conditions. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Take one tablet daily with food or as directled by a physician. Nicadan™ tablets are scored, so they may be broken in half if required.
www.medimetriks.comRx Only
Niacinamide, Vitamin B6, Vitamin C, Folic Acid,
Copper, Magnesium, Zinc & Alpha Lipoic Acid
Nicadan™ tablets are a specially formulated dietary supplement containing natural ingredients with anti-inflammatory properties. Each pink-coated tablet is oval shaped, scored and embossed with "MM". Nicadan™ is for oral administration only.
Nicadan™ should be administered under the supervision of a licensed medical practitioner.
Each tablet of Nicadan™ contains:
| Vitamin C (as Ascorbic Acid) | 100 mg |
| Niacinamide (Vitamin B-3) | 800 mg |
| Vitamin B-6 (as Pyridoxine HCI) | 10 mg |
| Folic Acid | 500 mcg |
| Magnesium (as Magnesium Citrate) | 5 mg |
| Zinc (as Zinc Gluconate) | 20 mg |
| Copper (as Copper Gluconate) | 2 mg |
| Alpha Lipoic Acid | 50 mg |
Other Ingredients: Microcrystalline cellulose, Povidone, Hypromellose, Croscarmellose Sodium, Polydextrose, Talc, Magnesium Sterate Vegetable, Vegetable Stearine, Red Beet Powder, Titanium Dioxide, Maltodextrin and Triglycerides.
Nicadan™ is free of yeast, wheat, dairy, egg, soy, gluten, artificial color or flavors, added sugar, starch and preservatives.
As a dietary supplement, Nicadan™ tablets are beneficial in maintaining overall skin health, especially in patients with inflammatory skin conditions.1
1 This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
If you are pregnant, nursing or taking medication, consult your doctor before use.
Use of Nicadan™ is contraindicated in patients who are hypersensitive to any ingredient in this tablet.
There have been reports of GI upset, nausea, vomiting, heartburn, diarrhea, dizziness, drowsiness or headache with large doses of niacinamide. Rarely, niacinamide in doses of 3 grams/day or more has been associated with elevated liver function tests. There are case reports in the literature indicating that niacinamide may reduce the hepatic metabolism of primidone and carbamazepine. Individuals taking these medications should consult their physician. Individuals taking antidiabetes medications should have their blood glucose levels monitored.
Allergic sensitization has been reported rarely following oral administration of folic acid. Folic acid above 1 mg daily may obscure pernicious anemia in that hematologic remission may occur while neurological manifestations remain progressive.
Take one tablet daily with food or as directled by a physician. Nicadan™ tablets are scored, so they may be broken in half if required.
Nicadan™ is available in a bottle containing 60 tablets. 43538-440-60
Store at 15°C to 30°C (59°F to 86°F). Keep bottle tightly closed. Store in cool dry place.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
You may report side effects by calling 1-973-882-7512.
Manufactured for:
MEDIMETRIKS
PHARMACEUTICALS, INC.
383 Route 46 West, Fairfield, NJ 07004-2402 USA
Iss: 2/2014
IP038
43538-440-60
Rx Only
NICADAN™
Niacinamide, Vitamin B6, Vitamin C, Folic Acid,
Copper, Magnesium, Zinc & Alpha Lipoic Acid
Helps Maintain Overall
Skin Health†
Dermatologist
Developed
60 Tablets
Dietary Supplement
MEDIMETRIKS
PHARMACEUTICALS, INC.
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43538-440-60 | Nicadan | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 1 | |
| 43538-440-60 | Nicadan | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43538-440 | NICADAN (ASCORBIC ACID, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, MAGNESIUM CITRATE, ZINC GLUCONATE, COPPER GLUCONATE, AND .ALPHA.-LIPOIC ACID) TABLET, FILM COATED [MEDIMETRIKS PHARMACEUTICALS, INC.] | 1 | 2 package rows | 20140228_758f439c-8202-4e7a-a07f-8adcabdae51d.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43538-440-60 | EA - Each | 43538-440 | 0e72f488-15a8-48dd-8969-f86c51b1630c | 1 | 2014-04-03 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .alpha.-lipoic acid | ACTIVE INGREDIENT | 73Y7P0K73Y | 1 | |
| Ascorbic Acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| copper gluconate | ACTIVE INGREDIENT | RV823G6G67 | 1 | |
| folic acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| magnesium citrate | ACTIVE INGREDIENT | RHO26O1T9V | 1 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| pyridoxine hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| zinc gluconate | ACTIVE INGREDIENT | U6WSN5SQ1Z | 1 | |
| .alpha.-lipoic acid | ACTIVE MOIETY | 73Y7P0K73Y | 1 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| cupric cation | ACTIVE MOIETY | 8CBV67279L | 1 | |
| folic acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| magnesium cation | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| zinc cation | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| maltodextrin | INACTIVE INGREDIENT | 7CVR7L4A2D | 1 | |
| polydextrose | INACTIVE INGREDIENT | VH2XOU12IE | 1 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43538-440 | 43538-440-60 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Ascorbic Acid | PQ6CK8PD0R | ACTIB |
| Niacinamide | 25X51I8RD4 | ACTIB |
| pyridoxine hydrochloride | 68Y4CF58BV | ACTIB |
| folic acid | 935E97BOY8 | ACTIB |
| magnesium citrate | RHO26O1T9V | ACTIB |
| zinc gluconate | U6WSN5SQ1Z | ACTIB |
| copper gluconate | RV823G6G67 | ACTIM |
| .alpha.-lipoic acid | 73Y7P0K73Y | ACTIB |
| cellulose, microcrystalline | OP1R32D61U | IACT |
| povidones | FZ989GH94E | IACT |
| hypromelloses | 3NXW29V3WO | IACT |
| croscarmellose sodium | M28OL1HH48 | IACT |
| polydextrose | VH2XOU12IE | IACT |
| talc | 7SEV7J4R1U | IACT |
| titanium dioxide | 15FIX9V2JP | IACT |
| maltodextrin | 7CVR7L4A2D | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| povidones | POVIDONE | FZ989GH94E | SUSPENSION / AURICULAR (OTIC) | NA | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| talc | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| talc | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | INJECTION / INTRAMUSCULAR | 1 %w/v | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, FOR SUSPENSION / ORAL | 1875 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GUM, CHEWING / BUCCAL | 182 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, EXTENDED RELEASE / ORAL | 53 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| talc | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | 45 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TROCHE / ORAL | 50 mg | ||
| talc | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | TABLET, COATED / ORAL | 5.6 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | 250 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| povidones | POVIDONE | FZ989GH94E | SOLUTION / ORAL | 3000 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET, COATED / ORAL | 49.2 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| povidones | POVIDONE | FZ989GH94E | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM / BUCCAL | 3 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| povidones | POVIDONE | FZ989GH94E | INJECTION / INTRAMUSCULAR | 0.2 %w/v | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED PELLETS / ORAL | 4.4 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | 41 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING / ORAL | 6 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| povidones | POVIDONE | FZ989GH94E | TABLET / SUBLINGUAL | 6 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, COATED PELLETS / ORAL | 198 mg | ||
| maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | FILM, SOLUBLE / ORAL | 19 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | ||
| talc | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CREAM / TOPICAL | 0.1 %w/w | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | GRANULE, FOR SUSPENSION / ORAL | 282 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SOLUTION / OPHTHALMIC | 0.5 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Adverse event summaries are temporarily unavailable. Other product information remains available.